Analytic Investors’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$3.62M Sell
178,294
-43,597
-20% -$878K 0.04% 219
2016
Q2
$4.16M Buy
221,891
+19,188
+9% +$353K 0.05% 200
2016
Q1
$3.63M Buy
202,703
+70,550
+53% +$1.21M 0.04% 233
2015
Q4
$2.27M Buy
132,153
+11,947
+10% +$201K 0.03% 276
2015
Q3
$1.94M Buy
120,206
+43,821
+57% +$735K 0.03% 294
2015
Q2
$1.32M Buy
76,385
+32,467
+74% +$545K 0.02% 338
2015
Q1
$725K Buy
+43,918
New +$680K 0.01% 403
2014
Q1
Sell
-89,112
Closed -$1.48M 592
2013
Q4
$1.48M Buy
89,112
+39,960
+81% +$624K 0.02% 280
2013
Q3
$800K Sell
49,152
-28,146
-36% -$439K 0.01% 319
2013
Q2
$974K Buy
+77,298
New +$1.01M 0.02% 358

Other funds holding PETS

Analytic Investors's PETS Position: Q3 2016 in Review

Analytic Investors reduced its PetMed Express (PETS) stake by 20% in Q3 2016, selling an estimated $878K and leaving 178,294 shares worth $3.62M. The position accounts for 0.04% of the portfolio, ranked #219.

Analytic Investors first reported a position in PETS in Q2 2013 and has held it in 10 quarters since. The position peaked at $4.16M in Q2 2016. 149 funds tracked by Wall St. Rank hold PETS as of Q3 2016.

  • Analytic Investors held 178,294 shares of PetMed Express worth $3.62M as of Q3 2016.
  • Analytic Investors sold 43,597 PetMed Express shares in Q3 2016, an estimated $878K.
  • PetMed Express made up 0.04% of Analytic Investors's portfolio in Q3 2016, its #219 holding.
  • Analytic Investors first reported a position in PetMed Express in Q2 2013 and has held it in 10 quarters since.
  • Analytic Investors's PetMed Express position peaked at $4.16M in Q2 2016.
  • 149 funds tracked by Wall St. Rank held PetMed Express as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.